The Neuenschwander Company

The Neuenschwander Company Promoting and facilitating wise development and sound deployment of medcation-use automation This led to further research.

The Neuenschwander Company provides reports, consulting services, lectures, and seminars, which promote and facilitate wise development and sound deployment of medication-use automation—giving particular attention to medication-technology safety systems. Download a partial menu of our consulting services here: http://www.hospitalrx.com/consultingservices.html. TNC was formed in 1993 when the autom

ated drug dispensing industry began its rapid growth. As Mark Neuenschwander began researching this virile field, he discovered that pharmacists, nurses and hospital administrators lacked the time and budget for doing the diligence necessary for evaluating the emerging systems they were responsible for acquiring and implementing. Soon Mark discovered there was no independent, unbiased entity that disseminated the kind of information crucial for good decision making. Early in 1994, under the banner of Hospital Reports, the first edition of what has become The Neuenschwander Reports was published. Today, these reports are utilized by hundreds of healthcare decision makers throughout the U.S. and Canada, as well as Europe, Asi, Latin America, and Australia. Over two decades the company’s vision and expertise have grown to encompass other medication-use technologies, including bar-code medication administration BCMA systems and bar-code-enabled medication preparation (BCMP) systems. The Neuenschwander Company...when you need to know about medication-use automation.™

04/09/2024

Some people brought a blind man to Jesus and begged for help. After touching the man’s eyes, Jesus asked if he now saw anything. “I see people, sort of like trees walking.” So, Jesus touched the man’s eyes a second time. When they were opened, he saw everything clearly. It took the first two...

There is not a person who reads this who does not owe a debt of gratitude to my dear friend, Michael R. Cohen—the God-se...
04/27/2022

There is not a person who reads this who does not owe a debt of gratitude to my dear friend, Michael R. Cohen—the God-sent founder of the Institute for Safe Medication Practices (ISMP). As I've tagged him in this post, feel free to use comments to add your thanks!

Mike Cohen, the founder of ISMP, talks about the journey he took with this organization.

Thanks Pharmacy Practice News! Grateful for the opportunity to be heard.
04/05/2022

Thanks Pharmacy Practice News! Grateful for the opportunity to be heard.

Medication safety experts are urging various regulatory bodies to make IV workflow management systems mandatory, based on the technology’s track record for preventing catastrophic medication errors.

Would you lend me 3 minutes to introduce you to THRIV?
01/21/2021

Would you lend me 3 minutes to introduce you to THRIV?

12/04/2020

Tune into the Virtual Cheers Awards in 6 days to hear from all of this year's winners!

Register Now: https://ismp.org/events/23rd-annual-cheers-awards-registration

Tina Suess is receiving a Cheers Award for her exceptional leadership in the healthcare information technology industry on a national level, as well as in her own community hospital.

When Patrician Kienle communicates, I listen. Clear, concise, and always helpful. True to form, she's spot-on in this in...
12/03/2020

When Patrician Kienle communicates, I listen. Clear, concise, and always helpful. True to form, she's spot-on in this interview.

"There are potential error points throughout every step of IV preparation when using a manual process. For example, the wrong drug, volume, dose, solution, or diluent could be used. The drugs could be mixed in the wrong order. The technique used could be incorrect. Implementing IV workflow software is necessary to prevent these types of human errors. To ensure medication safety, whatever processes can be automated should be automated."

Ensuring Safety in the IV Process : November 2020 - PP&P Magazine - Online Health-System Pharmacy Best Practices and Purchasing Guidance

12/01/2020

Technologies like IV robotics and workflow solutions are generating proven results when it comes to increasing sterile compounding accuracy and safety....

09/17/2020

ECRI and ISMP are joining global healthcare leaders in recognizing on September 17!

For free resources and a “Speak Up” video that support this year’s theme of health worker safety, see: https://www.ecri.org/world-patient-safety-day-2020

Spot on, ISMP!
08/13/2020

Spot on, ISMP!

Featured Articles CSP Accuracy and Error Prevention Should Be Both a Leadership and Regulatory Mandate August 13, 2020 Millions of compounded sterile preparations (CSPs) are produced each year, many in hospital pharmacies. The inherent risks in the sterile compounding process are numerous and includ...

Proper sterile garb can be expensive, upward of $100 per person per gowning incident, Mr. Kastango said. But it is a nec...
06/23/2020

Proper sterile garb can be expensive, upward of $100 per person per gowning incident, Mr. Kastango said. But it is a necessary expense. “The dirtiest thing in the cleanroom is us.”

With sterile compounding, there is little to no room for error. Optimizing methods to ensure the highest level of safety for patients and staff—and to fall in line with the ever-changing rules and regulations—is more critical and challenging than ever.

Celebrating Nurses' Month
05/15/2020

Celebrating Nurses' Month

NURSES’ MONTH I’ve been thinking about Florence, pledges, harm, and help. In 1893, nursing pioneer, Lystra Gretter, passed on the light of “The Lady with the Lamp” in penning the Florence Nightingale Nurse’s Pledge. Reminiscent of the Hippocratic Oath, the pledge included a commitment: “...

YES!
05/07/2020

YES!

Address

Bellevue, WA
98008

Alerts

Be the first to know and let us send you an email when The Neuenschwander Company posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Contact The Business

Send a message to The Neuenschwander Company:

Featured

Share